Cargando…

Cardiac Sympathetic Activity and Rhythm Control Following Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation—A Prospective (123)I-mIBG-SPECT/CT Imaging Study

Background: Pulmonary vein isolation (PVI) and antiarrhythmic drug therapy are established treatment strategies to preserve sinus rhythm in atrial fibrillation (AF). However, the efficacy of both interventional and pharmaceutical therapy is still limited. Solid evidence suggests an important role of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lange, Philipp S., Wenning, Christian, Avramovic, Nemanja, Leitz, Patrick, Larbig, Robert, Frommeyer, Gerrit, Schäfers, Michael, Eckardt, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549007/
https://www.ncbi.nlm.nih.gov/pubmed/34683135
http://dx.doi.org/10.3390/jpm11100995
_version_ 1784590701498990592
author Lange, Philipp S.
Wenning, Christian
Avramovic, Nemanja
Leitz, Patrick
Larbig, Robert
Frommeyer, Gerrit
Schäfers, Michael
Eckardt, Lars
author_facet Lange, Philipp S.
Wenning, Christian
Avramovic, Nemanja
Leitz, Patrick
Larbig, Robert
Frommeyer, Gerrit
Schäfers, Michael
Eckardt, Lars
author_sort Lange, Philipp S.
collection PubMed
description Background: Pulmonary vein isolation (PVI) and antiarrhythmic drug therapy are established treatment strategies to preserve sinus rhythm in atrial fibrillation (AF). However, the efficacy of both interventional and pharmaceutical therapy is still limited. Solid evidence suggests an important role of the cardiac sympathetic nervous system in AF. In this blinded, prospective observational study, we studied left ventricular cardiac sympathetic activity in patients treated with PVI and with antiarrhythmic drugs. Prospectively, Iodine-123-benzyl-guanidine single photon emission computer tomography ((123)I-mIBG-SPECT) was performed in a total of 23 patients with paroxysmal AF, who underwent PVI (n = 20) or received antiarrhythmic drug therapy only (n = 3), respectively. (123)I-mIBG planar and SPECT/CT scans were performed before and 4 to 8 weeks after PVI (or initiation of drug therapy, respectively). For semiquantitative SPECT image analysis, attenuation-corrected early/late images were analyzed. Quantitative SPECT analysis was performed using the AHA 17-segment model of the left ventricle. Results: PVI with point-by-point radiofrequency ablation led to a significantly (p < 0.05) higher visual sympathetic innervation defect score when comparing pre-and post PVI. Newly emerging innervation deficits post PVI were localized predominantly in the inferior lateral wall. These findings were corroborated by semiquantitative SPECT analysis identifying inferolateral segments with a reduced tracer uptake in comparison to SPECT before PVI. Following PVI, patients with an AF relapse showed a different sympathetic innervation pattern compared to patients with sufficient rhythm control. Conclusions: PVI results in novel defects of cardiac sympathetic innervation. Differences in cardiac sympathetic innervation remodelling following PVI suggest an important role of the cardiac autonomous nervous system in the maintenance of sinus rhythm following PVI.
format Online
Article
Text
id pubmed-8549007
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85490072021-10-28 Cardiac Sympathetic Activity and Rhythm Control Following Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation—A Prospective (123)I-mIBG-SPECT/CT Imaging Study Lange, Philipp S. Wenning, Christian Avramovic, Nemanja Leitz, Patrick Larbig, Robert Frommeyer, Gerrit Schäfers, Michael Eckardt, Lars J Pers Med Article Background: Pulmonary vein isolation (PVI) and antiarrhythmic drug therapy are established treatment strategies to preserve sinus rhythm in atrial fibrillation (AF). However, the efficacy of both interventional and pharmaceutical therapy is still limited. Solid evidence suggests an important role of the cardiac sympathetic nervous system in AF. In this blinded, prospective observational study, we studied left ventricular cardiac sympathetic activity in patients treated with PVI and with antiarrhythmic drugs. Prospectively, Iodine-123-benzyl-guanidine single photon emission computer tomography ((123)I-mIBG-SPECT) was performed in a total of 23 patients with paroxysmal AF, who underwent PVI (n = 20) or received antiarrhythmic drug therapy only (n = 3), respectively. (123)I-mIBG planar and SPECT/CT scans were performed before and 4 to 8 weeks after PVI (or initiation of drug therapy, respectively). For semiquantitative SPECT image analysis, attenuation-corrected early/late images were analyzed. Quantitative SPECT analysis was performed using the AHA 17-segment model of the left ventricle. Results: PVI with point-by-point radiofrequency ablation led to a significantly (p < 0.05) higher visual sympathetic innervation defect score when comparing pre-and post PVI. Newly emerging innervation deficits post PVI were localized predominantly in the inferior lateral wall. These findings were corroborated by semiquantitative SPECT analysis identifying inferolateral segments with a reduced tracer uptake in comparison to SPECT before PVI. Following PVI, patients with an AF relapse showed a different sympathetic innervation pattern compared to patients with sufficient rhythm control. Conclusions: PVI results in novel defects of cardiac sympathetic innervation. Differences in cardiac sympathetic innervation remodelling following PVI suggest an important role of the cardiac autonomous nervous system in the maintenance of sinus rhythm following PVI. MDPI 2021-09-30 /pmc/articles/PMC8549007/ /pubmed/34683135 http://dx.doi.org/10.3390/jpm11100995 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lange, Philipp S.
Wenning, Christian
Avramovic, Nemanja
Leitz, Patrick
Larbig, Robert
Frommeyer, Gerrit
Schäfers, Michael
Eckardt, Lars
Cardiac Sympathetic Activity and Rhythm Control Following Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation—A Prospective (123)I-mIBG-SPECT/CT Imaging Study
title Cardiac Sympathetic Activity and Rhythm Control Following Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation—A Prospective (123)I-mIBG-SPECT/CT Imaging Study
title_full Cardiac Sympathetic Activity and Rhythm Control Following Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation—A Prospective (123)I-mIBG-SPECT/CT Imaging Study
title_fullStr Cardiac Sympathetic Activity and Rhythm Control Following Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation—A Prospective (123)I-mIBG-SPECT/CT Imaging Study
title_full_unstemmed Cardiac Sympathetic Activity and Rhythm Control Following Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation—A Prospective (123)I-mIBG-SPECT/CT Imaging Study
title_short Cardiac Sympathetic Activity and Rhythm Control Following Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation—A Prospective (123)I-mIBG-SPECT/CT Imaging Study
title_sort cardiac sympathetic activity and rhythm control following pulmonary vein isolation in patients with paroxysmal atrial fibrillation—a prospective (123)i-mibg-spect/ct imaging study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549007/
https://www.ncbi.nlm.nih.gov/pubmed/34683135
http://dx.doi.org/10.3390/jpm11100995
work_keys_str_mv AT langephilipps cardiacsympatheticactivityandrhythmcontrolfollowingpulmonaryveinisolationinpatientswithparoxysmalatrialfibrillationaprospective123imibgspectctimagingstudy
AT wenningchristian cardiacsympatheticactivityandrhythmcontrolfollowingpulmonaryveinisolationinpatientswithparoxysmalatrialfibrillationaprospective123imibgspectctimagingstudy
AT avramovicnemanja cardiacsympatheticactivityandrhythmcontrolfollowingpulmonaryveinisolationinpatientswithparoxysmalatrialfibrillationaprospective123imibgspectctimagingstudy
AT leitzpatrick cardiacsympatheticactivityandrhythmcontrolfollowingpulmonaryveinisolationinpatientswithparoxysmalatrialfibrillationaprospective123imibgspectctimagingstudy
AT larbigrobert cardiacsympatheticactivityandrhythmcontrolfollowingpulmonaryveinisolationinpatientswithparoxysmalatrialfibrillationaprospective123imibgspectctimagingstudy
AT frommeyergerrit cardiacsympatheticactivityandrhythmcontrolfollowingpulmonaryveinisolationinpatientswithparoxysmalatrialfibrillationaprospective123imibgspectctimagingstudy
AT schafersmichael cardiacsympatheticactivityandrhythmcontrolfollowingpulmonaryveinisolationinpatientswithparoxysmalatrialfibrillationaprospective123imibgspectctimagingstudy
AT eckardtlars cardiacsympatheticactivityandrhythmcontrolfollowingpulmonaryveinisolationinpatientswithparoxysmalatrialfibrillationaprospective123imibgspectctimagingstudy